Treatment  	Treatment  	 NN	O
and  	and  	 CC	O
timing  	timing  	 NN	O
in  	in  	 IN	O
invasive  	invasive  	 FW	B-NP
mould  	mould  	 FW	I-NP
disease  	disease  	 FW	I-NP
Invasive  	Invasive  	 FW	I-NP
mould  	mould  	 FW	I-NP
disease  	disease  	 NN	I-NP
is  	is  	 VBZ	O
a  	a  	 DT	O
growing  	growing  	 VBG	B-NP
threat  	threat  	 NN	I-NP
for  	for  	 IN	I-NP
immunocompromised  	immunocompromised  	 JJ	I-NP
patients 	patients 	 NNS	I-NP
.  	.  	 .	O
The  	The  	 DT	O
optimum  	optimum  	 JJ	B-NP
time  	time  	 NN	I-NP
to  	to  	 TO	O
use  	use  	 VB	O
mould-active  	mould-active  	 JJ	B-NP
antifungal  	antifungal  	 JJ	I-NP
agents  	agents  	 NNS	I-NP
is  	is  	 VBZ	O
much  	much  	 RB	O
debated 	debated 	 VBN	O
.  	.  	 .	O
Current  	Current  	 JJ	B-NP
approaches  	approaches  	 NNS	I-NP
to  	to  	 TO	O
antifungal  	antifungal  	 VB	O
prophylaxis 	prophylaxis 	 NNS	B-NP
,  	,  	 ,	O
early  	early  	 JJ	O
treatment  	treatment  	 NN	O
( 	( 	 -LRB-	O
empirical  	empirical  	 NN	O
and  	and  	 CC	O
pre-emptive  	pre-emptive  	 JJ	B-NP
therapy 	therapy 	 NN	I-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
treatment  	treatment  	 NN	O
of  	of  	 IN	O
documented  	documented  	 JJ	O
mould  	mould  	 JJ	O
infections  	infections  	 NNS	O
in  	in  	 IN	O
onco-haematology  	onco-haematology  	 JJ	B-NP
patients  	patients  	 NNS	I-NP
are  	are  	 VBP	O
discussed 	discussed 	 VBN	O
.  	.  	 .	O
